Skip to content
WeighLab
Menu
Ranked #196 · Grade C

LillyDirect Foundayo review

Foundayo is Eli Lilly's own first-party, FDA-approved oral GLP-1 (orforglipron).

Visit LillyDirect Foundayo Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Yes

Pricing verified August 2026

The Index scorecard

LillyDirect Foundayo scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month45/100
Price Transparency54/100
Nationwide Access86/100
Formulation Options69/100
Clinical Oversight76/100
Contract Flexibility55/100

Where the value is

  • First-party Eli Lilly program -- highest possible manufacturer authenticity
  • FDA-approved branded drug (orforglipron), not an unapproved compounded formulation
  • Published self-pay starting price ($149) via savings card
  • Oral pill format, no injections/needles required

The tradeoffs

  • Not semaglutide or tirzepatide -- a different molecule (orforglipron), so not directly comparable on this list
  • The $149 price is tied to a specific Savings Card program with its own terms, not an unconditional list price
  • No clarity on whether $149 is truly the ongoing monthly cost or could change
  • No disclosed state coverage or prescribing-clinician details on this specific page

The bottom line

Best for: Patients who want an FDA-approved, manufacturer-direct oral GLP-1 rather than a compounded injectable. Foundayo is Eli Lilly's own first-party, FDA-approved oral GLP-1 (orforglipron).

Ranked #196 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to LillyDirect Foundayo.

The 24 programs nearest this one

Pricing, states and verification reflect LillyDirect Foundayo's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on LillyDirect Foundayo's site. Not medical advice; see our disclosure.

← Back to the value leaderboard